ABSTRACT
Most women who report increased levels of physical activity are not at an increased risk of preterm delivery or reduced intrauterine growth. This study was conducted to look into the safety and effects of regularly timed aerobic exercises during pregnancy on both the mother and the neonate. A prospective, case-control study was done on 120 healthy pregnant women in their first trimester. The data were collected in the prenatal outpatient care, labor and delivery rooms of a university-based Obstetrics Department. After completing basic information forms, the pregnant women were educated on the specific exercises in 8 stages throughout the pregnancy. Sixty-three patients presenting for delivery without any history of physical exercise were selected as the control group. There was no significant difference between the two groups regarding their occupation. The exercising group experienced significantly decreased durations of labor. There was no significant difference in neonatal birth weight or apgar scores. There were a significant decreased number of assisted deliveries in the exercising group. Exercise during pregnancy shortens the duration of the second stage of labor and reduces the risk of assisted delivery while is safe for the neonate too
Subject(s)
Humans , Female , Exercise/adverse effects , Pregnancy/complications , Pregnancy Outcome , Premature Birth/etiology , Fetal Growth Retardation/etiology , Case-Control Studies , Labor Stage, Second , Delivery, Obstetric/instrumentation , Prospective StudiesABSTRACT
En un estudio abierto, prospectivo a corto plazo se incluyeron 25 pacientes de uno u otro sexo, con edades comprendidas entre 16 a 60 años y con rigidez por cocntractura muscular consecutiva a traumatismo o ejercicio. A cada paceinte se le administró un nuevo mioespasmolítico: tizanidina por vía oral a dosis de 4 mg cada 8 horas durante 5 días. Se valoró en todos los casos, al inicio del estudio y a los 3 y 5 días de tratamiento el dolor espontáneo, el dolor a la palpación, la tensión muscular y la incapacidad funcional. También se valoraron los efectos seccundarios que se presentaron durante la administración de la tizanidina. Se notó una importante mejoría en los cuatro parámetros estudiados desde el tercer día de tratamiento, misma que se mantuvo hasta el final del estudio. El medicamento fue bien tolerado a dosis de 12 mg ya que el 68% de los pacientes no presentaron ningún efecto secundario. Se concluye que la tizanidina es una buena alternativa para el tratamiento de las contracturas musculares postraumáticas y por ejercicio